Dry Eye
Conditions
Interventions
3% diquafosol sodium group:The patients in the DQS group were given 3% DQS eye drops (5 ml: 150 mg, Santen Pharmaceutical (China) Co., Ltd.) starting the first day after surgery, one drop/time, four t
0.1% sodium hyaluronate group:The patients in the 0.1HA group received 0.1HA eye drops [5 ml: 5 mg, Santen Pharmaceutical (China) Co., Ltd.] starting the first day after surgery, one drop/time, four t
Sponsors
Nanning Bright Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were (1) the patient or his/her legal representative signed the study informed consent form after fully understanding the trial content, process, and potential adverse reactions and agreeing to be followed up at the time specified in the protocol, (2) =18 years of age, (3) met the indications for ICL surgery and intended to undergo ICL surgery, and (4) the target eye was confirmed without dry eye disease based on the diagnostic criteria from Chinese Experts Consensus of Dry Eye (2020 version)
Exclusion criteria
Exclusion criteria: The exclusion criteria were (1) the target eye had a history of other eye diseases that cause dry eye, (2) the patient had a history of other eye surgeries in the past 6 months (including a history of chalazion surgery), (3) the patients were taking any medication that causes dry eye, (4) active eye infections (such as blepharitis, infective conjunctivitis, keratitis, scleritis, iridocyclitis, endophthalmitis, etc.), or (5) uncontrollable diabetes, hypertension, heart disease, or other systemic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the best corrected visual acuity;tear BUT;tear meniscus height;SIT;dry eye-related quality of life score (DEQS); | — |
Countries
China
Contacts
Public ContactQianyun Zheng
Nanning Bright Eye Hospital
Outcome results
None listed